Wolverine Trading
CVAC

Wolverine Trading’s CureVac CVAC Stock Holding History

Wolverine Trading’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,024
Closed -$88.8K – 4163
2022
Q3 		$97K Buy
+12,024
New +$140K ﹤0.01% 3924
2021
Q4 		– Sell
-5,849
Closed -$321K – 6039
2021
Q3 		$321K Buy
+5,849
New +$352K ﹤0.01% 4599

Other funds holding CVAC

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wolverine Trading's CVAC Position: Q4 2022 in Review

Wolverine Trading sold out of CureVac (CVAC) in Q4 2022, closing a stake of 12,024 shares — an estimated $88.8K sold.

Wolverine Trading first reported a position in CVAC in Q3 2021 and held it in 2 quarters. The position peaked at $321K in Q3 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q4 2022.

  • Wolverine Trading reported no remaining CureVac position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 12,024 CureVac shares in Q4 2022, an estimated $88.8K.
  • Wolverine Trading first reported a position in CureVac in Q3 2021 and held it in 2 quarters.
  • Wolverine Trading's CureVac position peaked at $321K in Q3 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.